Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks.

Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S.

Neurology. 2004 Apr 27;62(8):1399-401.

PMID:
15111681
2.

Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.

Wahl A, Praz F, Tai T, Findling O, Walpoth N, Nedeltchev K, Schwerzmann M, Windecker S, Mattle HP, Meier B.

Heart. 2010 Jun;96(12):967-73. doi: 10.1136/hrt.2009.181156.

PMID:
20538672
3.

Migraine headache relief after transcatheter closure of patent foramen ovale.

Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA.

J Am Coll Cardiol. 2005 Feb 15;45(4):493-5.

4.

Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study.

Kimmelstiel C, Gange C, Thaler D.

Catheter Cardiovasc Interv. 2007 Apr 1;69(5):740-6.

PMID:
17295330
5.

Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study.

Chessa M, Colombo C, Butera G, Negura D, Piazza L, Varotto L, Bussadori C, Fesslova V, Meola G, Carminati M.

J Cardiovasc Med (Hagerstown). 2009 May;10(5):401-5.

PMID:
19449455
6.

Transcatheter closure of patent foramen ovale: a new migraine treatment?

Morandi E, Anzola GP, Angeli S, Melzi G, Onorato E.

J Interv Cardiol. 2003 Feb;16(1):39-42.

PMID:
12664816
7.

Patent foramen ovale, a possible cause of symptomatic migraine: a study of 74 patients with acute ischemic stroke.

Sztajzel R, Genoud D, Roth S, Mermillod B, Le Floch-Rohr J.

Cerebrovasc Dis. 2002;13(2):102-6.

PMID:
11867883
8.

Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.

Wahl A, Praz F, Findling O, Nedeltchev K, Schwerzmann M, Tai T, Windecker S, Mattle HP, Meier B.

Catheter Cardiovasc Interv. 2009 Jul 1;74(1):124-9. doi: 10.1002/ccd.21921.

PMID:
19180663
9.

Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.

Jesurum JT, Fuller CJ, Kim CJ, Krabill KA, Spencer MP, Olsen JV, Likosky WH, Reisman M.

Am J Cardiol. 2008 Oct 1;102(7):916-20. doi: 10.1016/j.amjcard.2008.05.035. Epub 2008 Jul 18.

PMID:
18805122
10.

Patent foramen ovale and migraine.

Post MC, Luermans JG, Plokker HW, Budts W.

Catheter Cardiovasc Interv. 2007 Jan;69(1):9-14. Review.

PMID:
17143907
11.

Prognosis after percutaneous closure of patent foramen ovale for paradoxical embolism.

Wahl A, Meier B, Haxel B, Nedeltchev K, Arnold M, Eicher E, Sturzenegger M, Seiler C, Mattle HP, Windecker S.

Neurology. 2001 Oct 9;57(7):1330-2.

PMID:
11591862
12.

Incidence, timing, and predictive factors of new-onset migraine headache attack after transcatheter closure of atrial septal defect or patent foramen ovale.

Rodés-Cabau J, Mineau S, Marrero A, Houde C, Mackey A, Côté JM, Chetaille P, Delisle G, Bertrand OF, Rivest D.

Am J Cardiol. 2008 Mar 1;101(5):688-92. doi: 10.1016/j.amjcard.2007.10.034. Epub 2007 Dec 21.

PMID:
18308022
13.

The influence of percutaneous atrial septal defect closure on the occurrence of migraine.

Mortelmans K, Post M, Thijs V, Herroelen L, Budts W.

Eur Heart J. 2005 Aug;26(15):1533-7. Epub 2005 Mar 3.

14.

Shunt-associated migraine responds favorably to atrial septal repair: a case-control study.

Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E.

Stroke. 2006 Feb;37(2):430-4. Epub 2005 Dec 22.

15.

Headache in 25 consecutive patients with atrial septal defects before and after percutaneous closure--a prospective case series.

Riederer F, Baumgartner H, Sándor PS, Wessely P, Wöber C.

Headache. 2011 Sep;51(8):1297-304. doi: 10.1111/j.1526-4610.2010.01824.x. Epub 2011 Jan 26.

PMID:
21884084
16.

Implantation of a second closure device in patients with residual shunt after percutaneous closure of patent foramen ovale.

Schwerzmann M, Windecker S, Wahl A, Nedeltchev K, Mattle HP, Seiler C, Meier B.

Catheter Cardiovasc Interv. 2004 Dec;63(4):490-5.

PMID:
15558761
17.

Transcatheter closure of patent foramen ovale in patients with migraine headache.

Spies C, Schräder R.

J Interv Cardiol. 2006 Dec;19(6):552-7. Review.

PMID:
17107372
18.

Prevalence of patent foramen ovale in migraine patients with and without aura compared with stroke patients. A transcranial Doppler study.

Carod-Artal FJ, da Silveira Ribeiro L, Braga H, Kummer W, Mesquita HM, Vargas AP.

Cephalalgia. 2006 Aug;26(8):934-9.

PMID:
16886929
19.

Patent foramen ovale and migraine.

Diener HC, Kurth T, Dodick D.

Curr Pain Headache Rep. 2007 Jun;11(3):236-40. Review.

PMID:
17504652
20.

ICE-guided patent foramen ovale (PFO) closure with lastest-generation devices: the ideal strategy for PFO-related migraine?

Rigatelli G, Cardaioli P, Braggion G, Giordan M, Aggio S, Roncon L.

J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):633-5.

PMID:
17667037
Items per page

Supplemental Content

Write to the Help Desk